Literature DB >> 32947442

Pediatric Lower Limb Lengthening Using the PRECICE Nail: Our Experience With 50 Cases.

Alexios D Iliadis1, Valentina Palloni, Jonathan Wright, David Goodier, Peter Calder.   

Abstract

BACKGROUND: Limb lengthening using intramedullary externally controlled motorized devices is becoming increasingly popular. There is limited literature regarding their use in the pediatric and adolescent population. This study reviews outcomes on 50 consecutive cases of intramedullary lower limb lengthening surgery in this population.
METHODS: A retrospective review of all pediatric and adolescent patients treated in our institution by intramedullary lengthening for lower limb length discrepancy using the PRECICE and STRYDE intramedullary lengthening nails between 2013 and 2019. All patients were operated by a single surgeon. Data were prospectively recorded. We report on nail accuracy and reliability, consolidation index, time to full weight-bearing from completion of lengthening, joint range of movement, ASAMI bone and functional scores, presence of problems, obstacles and complications, and patient reported outcome measures (PROMS).
RESULTS: Fifty cases (43 femoral and 7 tibial nails) were performed in 42 patients (20 males, 48% and 22 females, 52%). Six patients had bilateral lengthening and 2 patients had sequential lengthening. There were 28 antegrade femoral, 13 retrograde femoral and 5 tibia PRECICE nails, 2 tibial and 2 femoral PRECICE STRYDE nails. Mean age at surgery was 15 years old (12 to 17). Mean preoperative length discrepancy was 49 mm (20 to 90). Mean achieved lengthening was 46.5 mm (20 to 80). Mean percentage lengthening was 12.6% (5% to 25%). Nail accuracy was 96% and reliability 90%. Average distraction rate was 0.92 mm/d for femur and 0.64 mm/d for tibias. Consolidation index was 28 d/cm (18 to 43) and 39 d/cm (20 to 47), respectively. Time from completion of lengthening to independent full weight-bearing as observed in clinic was 45 days (21 to 70) and 34.2 days (23 to 50), respectively. ASAMI bone and functional scores were favorable and PROMS demonstrated high patient satisfaction levels. No significant complications were observed.
CONCLUSIONS: We have demonstrated excellent clinical results and high patient satisfaction with intramedullary lengthening in a pediatric/adolescent population. We highly recommend thorough preoperative preparation, patient education, and a multidisciplinary approach. LEVEL OF EVIDENCE: Level IV.

Entities:  

Mesh:

Year:  2021        PMID: 32947442     DOI: 10.1097/BPO.0000000000001672

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  5 in total

1.  What Factors Correlate With Length of Stay and Readmission After Limb Lengthening Procedures? A Large-database Study.

Authors:  Ashish Mittal; Sachin Allahabadi; Rishab Jayaram; Abhinav Nalluri; Matt Callahan; Sanjeev Sabharwal
Journal:  Clin Orthop Relat Res       Date:  2022-03-30       Impact factor: 4.755

2.  Technical considerations and early results of magnetic compressive intramedullary nailing for humeral shaft delayed unions and nonunions.

Authors:  Daniel J Cognetti; Abdullah Ghali; Jose M Gutierrez-Naranjo; Jordan Handcox; Ravi Karia; Anil K Dutta
Journal:  JSES Int       Date:  2022-01-17

3.  Use of the Pixel Value Ratio Following Intramedullary Limb Lengthening: Uncomplicated Full Weight-bearing at Lower Threshold Values.

Authors:  Ahmed A Elsheikh; Jonathan Wright; Michael T Stoddart; David Goodier; Peter Calder
Journal:  Strategies Trauma Limb Reconstr       Date:  2022 Jan-Apr

4.  Complications in Elective Removal of 271 Bone Lengthening Nails (FITBONE, PRECICE and STRYDE).

Authors:  Markus W Frost; Søren Kold; Ole Rahbek; Anirejuoritse Bafor; Molly Duncan; Christopher A Iobst
Journal:  Strategies Trauma Limb Reconstr       Date:  2021 May-Aug

Review 5.  Complication of lengthening and the role of post-operative care, physical and psychological rehabilitation among fibula hemimelia.

Authors:  Maryam Salimi; Rojin Sarallah; Salar Javanshir; Seyed Peyman Mirghaderi; Amirhossein Salimi; Shokoufeh Khanzadeh
Journal:  World J Clin Cases       Date:  2022-08-26       Impact factor: 1.534

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.